BIORISE Trademark

Trademark Overview

On Monday, October 5, 2020, a trademark application was filed for BIORISE with the United States Patent and Trademark Office. The USPTO has given the BIORISE trademark a serial number of 79297006. The federal status of this trademark filing is REGISTERED as of Tuesday, June 29, 2021. This trademark is owned by Biosensors Europe S.A.. The BIORISE trademark is filed in the Medical Instrument Products category with the following description:

Coronary balloon dilatation catheters for angioplasty
biorise

General Information

Serial Number79297006
Word MarkBIORISE
Filing DateMonday, October 5, 2020
Status700 - REGISTERED
Status DateTuesday, June 29, 2021
Registration Number6399066
Registration DateTuesday, June 29, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesCoronary balloon dilatation catheters for angioplasty

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, October 30, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiosensors Europe S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameBiosensors Europe S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameBiosensors Europe S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, April 9, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, August 28, 2021NOTIFICATION PROCESSED BY IB
Wednesday, August 11, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, August 11, 2021FINAL DISPOSITION PROCESSED
Thursday, July 29, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 29, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Monday, April 12, 2021NOTIFICATION PROCESSED BY IB
Wednesday, March 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 4, 2021ASSIGNED TO EXAMINER
Thursday, November 5, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, November 5, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, November 3, 2020APPLICATION FILING RECEIPT MAILED
Friday, October 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 29, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

biorise angioplasty catheters dilatation balloon coronary